Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2001

View Archived Issues

Inspire's agent for dry eye enters phase III evaluation

ID Biomedical seeks clearance to initiate phase I/II clinical trial of StreptAvax

New agreement assigns Schering worldwide rights to Epix Medical's MS-325

Good tolerability reported in phase I trial of CETP vaccine

Antex Biologics' Campylobacter vaccine shows promise in phase II

Immunotherapeutic agent enters phase II for genital warts

Ilex submits IND to FDA for angiogenesis inhibitor NM-3

Significant neuroprotection obtained in animal models with neuronal Ca2+ channel blockers

IMP dehydrogenase inhibitors potentiate anti-HBV activity of nucleoside analogues

Encouraging clinical data reported for Neotrofin in Alzheimer's disease

Acute and chronic antidiuretic effects of OPC-51803, a nonpeptide V2 receptor agonist

Mechanism by which metformin lowers glucose production elucidated

Dendreon to commence clinical trials of APC-8024 in cancer patients

Medarex and Novo Nordisk codevelop antibodies with broad therapeutic applications

Second phase II trial of HuMax-CD4 launched in patients with severe psoriasis

FDA clearance sought to begin clinical trials of levovirin

Positive opinion emitted by FDA committee for antifungal drug for invasive aspergillosis

FDA approves Femara for first-line treatment of breast cancer

Small-molecule insulin sensitizer slated to begin human testing next month

Novel glucose uptake enhancers presented by Telik

European arm of pivotal trial of dexanabinol in TBI begins

Gadolinium-based contrast agents for MRI patented by Guerbet

Scriptgen describes new antisickling agents identified using a novel method

Natural antihypertensive compound discovered in Brazilian plant

Novel series from Pfizer for use in hyperproliferative conditions

Preparation and use of cyclin-dependent kinase inhibitors

Recent patent covers new macrolides in development at Pfizer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...